The Primary Reasons People Participate in Maternal‐Fetal Phase I Clinical Trials Are Psychosocial
Ethics & Human Research · 2026-11 · 48 (6) · 20-31
DOI: 10.1002/eahr.70025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ethics & Human Research, online erschienen am 06.11.2026. Verfasst von Julia E H Brown und 6 weiteren Autor:innen. Beteiligte Einrichtung: Senior research fellow at the Monash Bioethics Center at Monash University. Hauptthemen laut MEDLINE: Clinical Trials, Phase I as Topic, Motivation, Research Subjects. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHGRI NIH HHS, National Human Genome Research Institute.
Abstract (Originalsprache)
Recent critiques of ethical guidance for maternal‐fetal therapy clinical trials has highlighted the need to weigh maternal, fetal, and societal interests, respectively, while deprioritizing psychosocial reasons for participation. Psychosocial reasons refer to the psychological and social influences on study participants’ decisions, and they are often central to considerations about informed consent. However, psychosocial reasons are described as too indirect, subjective, and vague to incorporate into prenatal clinical and regulatory frameworks. This qualitative study examined the perspectives of 11 individuals (within eight couples) enrolled in one of two maternal‐fetal therapy phase I clinical trials for rare genetic conditions. Interviews revealed that motivations to participate were primarily psychosocial, including existential concerns given prior bereavement and/or fear of loss; temporal control through taking action as opposed to feeling passive; hope and optimism; and intergenerational and social motivations given one's family experience with disease and desire for social connections. Psychosocial reasons for participating ought to be given more consideration in ethical frameworks for maternal‐fetal therapy phase I clinical trials, as well as in the approach to informed consent. It is important for clinical research teams to be especially conscientious to ensure appreciation for participants’ reasons for participating that extend beyond typical frameworks of clinical risk/benefit, and to support participants who might harbor optimistic expectations of medical procedures as they transition to postnatal realities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Senior research fellow at the Monash Bioethics Center at Monash University.
- Researcher at the University of California, San Francisco.
- Program manager for the Center of Genome Surgery at the University of California, San Francisco.
- Perinatal genetic counselor at the University of California, San Francisco.
- Division head of pediatric neurology and a professor in the Department of Pediatrics at the University of British Columbia and BC Children's Hospital.
- Associate professor of maternal-fetal medicine and clinical genetics at the University of California, San Francisco.
Förderung
- NHGRI NIH HHS
- National Human Genome Research Institute
Zitieren
APA
Brown, J. E. H., Riddle, L. S., Canepa, E., Lianoglou, B., Gano, D., Sparks, T. N., & Halpern, J. (2026). The Primary Reasons People Participate in Maternal‐Fetal Phase I Clinical Trials Are Psychosocial. Ethics & Human Research, 48(6), 20-31. https://doi.org/10.1002/eahr.70025
Vancouver
Brown JEH, Riddle LS, Canepa E, Lianoglou B, Gano D, Sparks TN, et al. The Primary Reasons People Participate in Maternal‐Fetal Phase I Clinical Trials Are Psychosocial. Ethics & Human Research. 2026;48(6):20-31. doi:10.1002/eahr.70025
BibTeX
@article{Brown2026,
author = {Brown, Julia E H and Riddle, Leslie S and Canepa, Emma and Lianoglou, Billie and Gano, Dawn and Sparks, Teresa N and Halpern, Jodi},
title = {The Primary Reasons People Participate in Maternal‐Fetal Phase I Clinical Trials Are Psychosocial},
journal = {Ethics & Human Research},
year = {2026},
volume = {48},
number = {6},
pages = {20--31},
doi = {10.1002/eahr.70025}
}
EUVIMED